Answers are grounded in this paper and cite their sources.
Objectives Gestational diabetes mellitus (GDM) is defined as glucose intolerance first detected during pregnancy and is associated with adverse maternal and neonatal outcomes. Metabolomics provides a system-level approach to characterize metabolic alterations associated with gestational insulin resistance. This study aimed to identify plasma metabolite differences between women with GDM and normal glucose tolerance (NGT) and to evaluate the discriminatory performance of a metabolite-based panel. Methods Plasma samples from 270 pregnant women (169 GDM and 101 NGT) were analyzed using an untargeted 1 H nuclear magnetic resonance ( 1 H NMR)–based metabolomics approach. Differential metabolites were identified using univariate, followed by multivariate modeling and regression adjustment for maternal age and pre-pregnancy body mass index. Discriminatory performance was evaluated using Random Forest (RF), Partial Least Squares–Discriminant Analysis (PLS-DA), and Linear Support Vector Machine (Linear-SVM) models with Receiver Operating Characteristic curve analysis. Pathway enrichment analyses were performed using KEGG and SMPDB, and disease-based enrichment was assessed using HMDB. Results Among 31 identified metabolites, 14 differed significantly between GDM and NGT. Integration of univariate and multivariate analyses prioritized nine metabolites—acetone, citrate, glucose, succinate, glycine, 3-hydroxybutyrate, leucine, phenylalanine, and the CH = CH bond of unsaturated lipids—that remained independently associated with GDM after covariate adjustment. All nine metabolites were elevated in the GDM group. A nine-metabolite panel achieved an area under the curve (AUC) of 0.76 (95% CI: 0.70–0.81) using the RF model. Pathway enrichment identified valine, leucine, and isoleucine biosynthesis and ketone body metabolism as significantly enriched pathways. HMDB-based disease enrichment showed overlap with preeclampsia-related metabolic signatures. Conclusion Untargeted 1 H NMR metabolomics, combined enrichment analyses, identified coordinated metabolic disturbances in GDM involving amino acid and ketone body metabolism. A nine-metabolite panel demonstrated moderate discriminative performance and provides mechanistic insight into GDM-associated metabolic adaptations, supporting their potential utility for future biomarker validation and translational studies.
No takes yet. Share an insight, caveat, or question.
Chaiyachate et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: